Early Menarche Associated with Increased Diabetes Risk
|
By HospiMedica International staff writers Posted on 15 Aug 2019 |
A new study suggests that early onset of menstruation is associated with higher risk of type 2 diabetes mellitus (T2DM), but that the effect may be partially mediated by body mass index (BMI).
Researchers at Zhengzhou University (Zhengzhou, China) conducted a study involving 15,346 postmenopausal women participating in the Henan province rural cohort study in order to determine if early menarche (i.e., under 14 years of age) is associated with an increased risk of T2DM, and to investigate whether the association was mediated by BMI adiposity.
The results revealed that after adjusting for multiple confounders, the early menarche group had a higher risk of T2DM compared with the reference group (16-17 years of age). Likewise, the late onset group (women in whom menarche occurred later that 19 years of age) had a lower risk of T2DM. The researchers also found that BMI partially mediated the association between age at menarche and T2DM, and the proportion of the effect was 28%. The study was published on July 29, 2019, in Menopause.
“This study of rural Chinese women indicates that the average age of menarche is delayed relative to western countries at 16.1 years, and is linked with lower risk of type 2 diabetes,” said Stephanie Faubion, MD, medical director of the North American Menopause Society (NAMS; Pepper Pike, OH, USA). “Earlier onset of menses was associated with diabetes in later life, likely driven by adult BMI. Other factors such as nutrition and BMI in childhood may also play a role in this association.”
Age at menarche is frequently used to explore the association between developmental tempo during puberty and disease risk. Earlier menarche has been associated with some adverse outcomes, including obesity, cardiovascular disease, some types of cancer, and mortality. Increasing rates of T2D in recent decades have occurred in parallel with a decline in the average age at menarche, with several studies reporting adverse metabolic consequences of early sexual maturation, such as increased blood glucose levels, impaired glucose tolerance, and insulin resistance. Part of the association could be explained by increased adiposity.
Related Links:
Zhengzhou University
Researchers at Zhengzhou University (Zhengzhou, China) conducted a study involving 15,346 postmenopausal women participating in the Henan province rural cohort study in order to determine if early menarche (i.e., under 14 years of age) is associated with an increased risk of T2DM, and to investigate whether the association was mediated by BMI adiposity.
The results revealed that after adjusting for multiple confounders, the early menarche group had a higher risk of T2DM compared with the reference group (16-17 years of age). Likewise, the late onset group (women in whom menarche occurred later that 19 years of age) had a lower risk of T2DM. The researchers also found that BMI partially mediated the association between age at menarche and T2DM, and the proportion of the effect was 28%. The study was published on July 29, 2019, in Menopause.
“This study of rural Chinese women indicates that the average age of menarche is delayed relative to western countries at 16.1 years, and is linked with lower risk of type 2 diabetes,” said Stephanie Faubion, MD, medical director of the North American Menopause Society (NAMS; Pepper Pike, OH, USA). “Earlier onset of menses was associated with diabetes in later life, likely driven by adult BMI. Other factors such as nutrition and BMI in childhood may also play a role in this association.”
Age at menarche is frequently used to explore the association between developmental tempo during puberty and disease risk. Earlier menarche has been associated with some adverse outcomes, including obesity, cardiovascular disease, some types of cancer, and mortality. Increasing rates of T2D in recent decades have occurred in parallel with a decline in the average age at menarche, with several studies reporting adverse metabolic consequences of early sexual maturation, such as increased blood glucose levels, impaired glucose tolerance, and insulin resistance. Part of the association could be explained by increased adiposity.
Related Links:
Zhengzhou University
Latest Patient Care News
- Wearable Sleep Data Predict Adherence to Pulmonary Rehabilitation
- Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care
- VR Training Tool Combats Contamination of Portable Medical Equipment
- Portable Biosensor Platform to Reduce Hospital-Acquired Infections
- First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds
- Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization

- Game-Changing Innovation in Surgical Instrument Sterilization Significantly Improves OR Throughput
- Next Gen ICU Bed to Help Address Complex Critical Care Needs
- Groundbreaking AI-Powered UV-C Disinfection Technology Redefines Infection Control Landscape
- Clean Hospitals Can Reduce Antibiotic Resistance, Save Lives
- Smart Hospital Beds Improve Accuracy of Medical Diagnosis
- New Fast Endoscope Drying System Improves Productivity and Traceability
- World’s First Automated Endoscope Cleaner Fights Antimicrobial Resistance
- Portable High-Capacity Digital Stretcher Scales Provide Precision Weighing for Patients in ER
- Portable Clinical Scale with Remote Indicator Allows for Flexible Patient Weighing Use
- Innovative and Highly Customizable Medical Carts Offer Unlimited Configuration Possibilities
Channels
Artificial Intelligence
view channel
Machine Learning Approach Enhances Liver Cancer Risk Stratification
Hepatocellular carcinoma, the most common form of primary liver cancer, is often detected late despite targeted surveillance programs. Current screening guidelines emphasize patients with known cirrhosis,... Read more
New AI Approach Monitors Brain Health Using Passive Wearable Data
Brain health spans cognitive and emotional functions and can fluctuate even in adults without diagnosed disease. Detecting early changes remains difficult in routine care and burdens specialty services... Read moreCritical Care
view channel
Automated IV Labeling Solution Improves Infusion Safety and Efficiency
Medication administration in high-acuity settings is often complicated by multiple concurrent infusions, making accurate line identification essential. In a 10-hospital intensive care unit study, 60% of... Read more
First-Of-Its-Kind AI Tool Detects Pulmonary Hypertension from Standard ECGs
Pulmonary hypertension is a progressive, life‑threatening disease that is frequently missed early because symptoms such as dyspnea are nonspecific and diagnostic delays can exceed two years.... Read moreSurgical Techniques
view channel
Continuous Monitoring with Wearables Enhances Postoperative Patient Safety
Postoperative hypoxemia on general surgical wards is common and often missed by intermittent vital sign checks. Undetected low oxygen levels can delay recovery and raise the risk of complications that... Read more
New Approach Enables Customized Muscle Tissue Without Biomaterial Scaffolds
Volumetric muscle loss is a traumatic loss of skeletal muscle that often leads to permanent functional impairment and limited reconstructive options. Current experimental strategies struggle to deliver... Read moreHealth IT
view channel
EMR-Based Tool Predicts Graft Failure After Kidney Transplant
Kidney transplantation offers patients with end-stage kidney disease longer survival and better quality of life than dialysis, yet graft failure remains a major challenge. Although a successful transplant... Read more
Printable Molecule-Selective Nanoparticles Enable Mass Production of Wearable Biosensors
The future of medicine is likely to focus on the personalization of healthcare—understanding exactly what an individual requires and delivering the appropriate combination of nutrients, metabolites, and... Read moreBusiness
view channel







